Category list : Anti-allergic agents

Sort by: Newest first Oldest first A-Z Z-A

Penicillin allergy: identification and management

4 SEP 2015 10:24 By Shilpa Jethwa

How to assess patients for true penicillin allergy and make appropriate treatment choices.
Hayfever symptoms Subscription

22 JUN 2015 11:23

8 June 2015: Royal Pharmaceutical Society spokesperson Elen Jones wrote an article in the Western Mail in Wales about hayfever and how people can visit a pharmacy to seek treatment for their symptoms.
Antihistamine could be used as a cheaper hepatitis C therapy, study suggests Subscription

10 APR 2015 11:46 By Andrea Chipman

Comments (1)

An anti-allergy treatment is effective in treating hepatitis C virus, a study has found, raising hopes of an affordable weapon in the fight against the virus.
Clinical Pharmacist's monthly news round-up: the top 10 in the past month Subscription

20 MAR 2015 16:48

What has been happening in the world of pharmacy? Here’s our pick of must-read news from the past month.
Older patients taking anticholinergic drugs are at risk of dementia Subscription

27 JAN 2015 18:18 By Debbie Andalo

Comments (1)

People aged over 65 years who take some common over-the-counter or prescribed medicines for allergy, depression or an overactive bladder have an increased risk of developing dementia.
Mistakes made by patients using medical devices points to need for better training Subscription

24 DEC 2014 10:37 By Debbie Andalo

A research team sought to identify the factors associated with incorrect use of metered-dose inhalers and epinephrine autoinjectors.
Alleviating allergies — and confusion Subscription

28 JUL 2014 9:55

7 July 2014: BBC television’s Your Money looked at how much viewers should be spending on hay fever medicines. RPS Chief Scientist Jayne Lawrence advised viewers that perceived differences between branded and generic antihistamines are probably due to the placebo effect. “If the patient has the same active ingredient at the same dose in the same type of formulation, for example a tablet, it’s very unlikely the patient will experience any difference between the branded and the generic ...
Asthma drug omalizumab approved for treatment of urticaria

7 MAR 2014 14:31

The monoclonal antibody omalizumab (Xolair) has been approved by the European Commission as an add-on therapy for the treatment of chronic spontaneous urticaria (CSU) in adults and adolescents with inadequate response to H1 antihistamine treatment.